Abstract |
Forty-five patients with presumed acute bacterial conjunctivitis were treated in an investigator-masked randomized multicenter study with either lomefloxacin 0.3% or fucidic acid 1% eye drops twice daily. Clinical signs and symptoms were rated by slit-lamp examination and conjunctival swab cultures were performed to evaluate clinical and microbiological efficacy. A total of 57 ocular isolates were tested for susceptibility to nine antibiotics. A significant decrease in clinical symptomatology was achieved by both treatments with a gradual improvement over the treatment period of 7-9 days. Bacteriological recovery was frequently achieved already at the first control visit (day 3-5), but the recovery rate was statistically significant (p = 0.014) only in the lomefloxacin group. The relatively high in vitro resistance rate (46%) to fucidic acid was not reflected by lower clinical efficacy. Two unrelated adverse events (one in each treatment group) and minimal local intolerance problems were observed in both treatment groups. A significantly higher incidence of burning sensation was observed with fucidic acid than with lomefloxacin (p < 0.01). All four treatment failures in the study occurred in the fucidic acid group. Lomefloxacin 0.3% ophthalmic solution demonstrated a high efficacy and good tolerance in the management of acute bacterial conjunctivitis.
|
Authors | K Malminiemi, O Kari, M L Latvala, R Voutilainen, A Miettinen, A Jauch |
Journal | Acta ophthalmologica Scandinavica
(Acta Ophthalmol Scand)
Vol. 74
Issue 3
Pg. 280-4
(Jun 1996)
ISSN: 1395-3907 [Print] Denmark |
PMID | 8828727
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Anti-Infective Agents
- Fluoroquinolones
- Ophthalmic Solutions
- Quinolones
- Fusidic Acid
- lomefloxacin
|
Topics |
- Acute Disease
- Administration, Topical
- Anti-Bacterial Agents
(administration & dosage, adverse effects, therapeutic use)
- Anti-Infective Agents
(administration & dosage, therapeutic use)
- Bacteria
(isolation & purification)
- Colony Count, Microbial
- Conjunctiva
(microbiology)
- Conjunctivitis, Bacterial
(drug therapy, pathology)
- Double-Blind Method
- Drug Resistance
- Fluoroquinolones
- Fusidic Acid
(administration & dosage, adverse effects, therapeutic use)
- Humans
- Microbial Sensitivity Tests
- Ophthalmic Solutions
- Quinolones
(administration & dosage, therapeutic use)
|